Shen Weili, Hao Jiejie, Tian Chuan, Ren Jinmin, Yang Lu, Li Xuesen, Luo Cheng, Cotma Carl W, Liu Jiankang
Institute for Nutritional Science, Shanghai Institutes of Biological Sciences, Chinese Academy of Sciences, Shanghai, China.
PLoS One. 2008 Jun 4;3(6):e2328. doi: 10.1371/journal.pone.0002328.
Recent evidence indicates that insulin resistance in skeletal muscle may be related to reduce mitochondrial number and oxidation capacity. However, it is not known whether increasing mitochondrial number and function improves insulin resistance. In the present study, we investigated the effects of a combination of nutrients on insulin resistance and mitochondrial biogenesis/function in skeletal muscle of type 2 diabetic Goto-Kakizaki rats.
METHODOLOGY/PRINCIPAL FINDINGS: We demonstrated that defect of glucose and lipid metabolism is associated with low mitochondrial content and reduced mitochondrial enzyme activity in skeletal muscle of the diabetic Goto-Kakizaki rats. The treatment of combination of R-alpha-lipoic acid, acetyl-L-carnitine, nicotinamide, and biotin effectively improved glucose tolerance, decreased the basal insulin secretion and the level of circulating free fatty acid (FFA), and prevented the reduction of mitochondrial biogenesis in skeletal muscle. The nutrients treatment also significantly increased mRNA levels of genes involved in lipid metabolism, including peroxisome proliferator-activated receptor-alpha (Ppar alpha), peroxisome proliferator-activated receptor-delta (Ppar delta), and carnitine palmitoyl transferase-1 (Mcpt-1) and activity of mitochondrial complex I and II in skeletal muscle. All of these effects of mitochondrial nutrients are comparable to that of the antidiabetic drug, pioglitazone. In addition, the treatment with nutrients, unlike pioglitazone, did not cause body weight gain.
CONCLUSIONS/SIGNIFICANCE: These data suggest that a combination of mitochondrial targeting nutrients may improve skeletal mitochondrial dysfunction and exert hypoglycemic effects, without causing weight gain.
最近的证据表明,骨骼肌中的胰岛素抵抗可能与线粒体数量减少和氧化能力降低有关。然而,尚不清楚增加线粒体数量和功能是否能改善胰岛素抵抗。在本研究中,我们调查了营养物质组合对2型糖尿病Goto-Kakizaki大鼠骨骼肌胰岛素抵抗和线粒体生物发生/功能的影响。
方法/主要发现:我们证明,糖尿病Goto-Kakizaki大鼠骨骼肌中葡萄糖和脂质代谢缺陷与线粒体含量低和线粒体酶活性降低有关。R-α-硫辛酸、乙酰-L-肉碱、烟酰胺和生物素的联合治疗有效改善了葡萄糖耐量,降低了基础胰岛素分泌和循环游离脂肪酸(FFA)水平,并防止了骨骼肌线粒体生物发生的减少。营养物质治疗还显著增加了参与脂质代谢的基因的mRNA水平,包括过氧化物酶体增殖物激活受体-α(Pparα)、过氧化物酶体增殖物激活受体-δ(Pparδ)和肉碱棕榈酰转移酶-1(Mcpt-1),以及骨骼肌中线粒体复合物I和II的活性。线粒体营养物质的所有这些作用与抗糖尿病药物吡格列酮相当。此外,与吡格列酮不同,营养物质治疗不会导致体重增加。
结论/意义:这些数据表明,线粒体靶向营养物质的组合可能改善骨骼肌线粒体功能障碍并发挥降血糖作用,而不会导致体重增加。